Workflow
肉奶周期反转
icon
Search documents
国泰海通证券:维持优然牧业“增持”评级 大股东定增彰显信心
Zhi Tong Cai Jing· 2026-01-19 03:05
国泰海通证券发布研报称,维持优然牧业(09858)"增持"评级。该行预计公司2025-27年营收分别为 208.55、230.18、258.42亿元,同比增长3.8%、10.4%、12.3%,归母净利润为2.18、18.37、42.82亿 元;EPS分别为0.06、0.47、1.10元/股。公司为牧业行业龙头,受益于周期反转红利,给予2026年公司1.6 倍P/B,对应目标价6.72港元/股。 国泰海通证券主要观点如下: 增发募资23亿港元,未来或推动牧场整合优化 1月16日公司订立配售及认购、特别授权认购协议,合计拟发行5.99亿股,约占交易前股本的15.4%;募 集资金净额为23.30亿港元,将用于偿还贷款及数字化转型建设等,公司持续推动降本增效与资产结构 优化。此外,周期底部资产收购性价比较高,公司未来或进一步整合优化牧场布局。 大股东定增彰显信心,持股比例将增至36% 公司拟向承配人(先旧后新配售方式)/伊利全资子公司博源投资(特别授股方式)均发行2.99亿股,约占交 易前股本的7.7%,发行价格为3.92港元/股(较1月15日收盘价折让8.8%),募集资金净额分别为 11.59/11.72亿港元,该 ...
国泰海通证券:维持优然牧业(09858)“增持”评级 大股东定增彰显信心
智通财经网· 2026-01-19 03:02
智通财经APP获悉,国泰海通证券发布研报称,维持优然牧业(09858)"增持"评级。该行预计公司2025- 27年营收分别为208.55、230.18、258.42亿元,同比增长3.8%、10.4%、12.3%,归母净利润为2.18、 18.37、42.82亿元;EPS分别为0.06、0.47、1.10元/股。公司为牧业行业龙头,受益于周期反转红利,给 予2026年公司1.6倍P/B,对应目标价6.72港元/股。 国泰海通证券主要观点如下: 增发募资23亿港元,未来或推动牧场整合优化 后备牛存栏持续去化,短期节奏不改长期趋势 春节备货影响短期节奏,后备牛存栏持续去化,节后成母牛补栏断档影响有望逐月体现。此外,玉米、 豆粕与苜蓿草价格环比回升,较前期低点增长7%/3%/14%,饲草料价格回升有望加速去化进程。随着 反补贴政策落地,我国乳制品深加工产业国产替代有望加速。受益于初深加工产能建设投产与供给端存 栏去化持续,26年奶价有望步入上行周期。肉牛周期景气向上,其中供给端能繁母牛持续去化,进口牛 肉保障政策落地提振国内牛肉需求。公司为牧业行业龙头,有望受益于肉奶周期反转,整体盈利弹性较 强。 风险提示 存栏去化 ...
国泰海通:维持现代牧业(01117)“增持”评级 目标价1.85港元
智通财经网· 2025-12-29 01:54
Group 1 - The core viewpoint of the report is that Cathay Pacific Haitong maintains a "buy" rating for Modern Dairy (01117), expecting EPS of 0.05 and 0.19 HKD per share for 2026 and 2027 respectively, benefiting from the reversal of the meat and milk cycle [1] - The company is progressing with the acquisition of China Shengmu, having signed an irrevocable voting proxy agreement on October 30, and plans to acquire 1.28% of shares for 37.52 million HKD, which will trigger a mandatory general offer [2] - The acquisition will integrate upstream resources from the major shareholder Mengniu, enhancing scale effects, with the total herd size expected to exceed 610,000 heads and raw milk production to surpass 4 million tons [3] Group 2 - The dairy cow inventory is accelerating its reduction due to ongoing financial pressures and a decrease in heifer restocking, with the impact expected to manifest monthly [4] - The Ministry of Commerce has announced preliminary rulings on anti-subsidy investigations against dairy products from the EU, imposing temporary anti-subsidy tax guarantees starting December 23, which is expected to accelerate domestic substitution in the dairy processing industry [4]
优然牧业(09858):原奶反转将至,龙头优先受益
Investment Rating - The report maintains an "Outperform" rating for China Youran Dairy [1][16] Core Views - The company is expected to benefit from an upcoming reversal in raw milk prices, entering a cycle of simultaneous growth in both volume and price [3][11][14] - The company has shown improved profitability, with a reduction in net losses and an increase in gross profit margin [10][12] - Cost control measures have been effective, leading to a significant rise in gross profit margin for the raw milk segment [12][13] Financial Performance - In H1 2025, the company achieved revenue of RMB 10.28 billion, a year-on-year increase of 2.3%, with a gross profit margin of 30.0% [10][11] - The net loss attributable to shareholders was reduced to RMB 297 million, reflecting a 10% year-on-year decrease in losses [10][11] - The company forecasts revenues of RMB 21.03 billion, RMB 23.16 billion, and RMB 25.55 billion for 2025, 2026, and 2027 respectively [15][16] Market Dynamics - The raw milk segment's revenue in H1 2025 was RMB 7.896 billion, with a sales volume increase of 15.8% year-on-year [11][14] - The current raw milk price has stabilized in the range of RMB 3.00 - 3.10 per kilogram, indicating a bottom consolidation phase [11][12] - The national dairy cattle inventory has decreased by 4.2% year-on-year, which is expected to support price recovery in the industry [14] Cost Management - Feeding costs decreased by 12% year-on-year to RMB 1.91 per kilogram, contributing to a lower unit cost of RMB 2.53 per kilogram [12][13] - The gross profit margin for the raw milk segment increased to 34.7%, demonstrating the company's operational efficiency [12][13] Capital Expenditure and Financial Resilience - Capital expenditures have declined, with significant reductions in spending on properties and biological assets [13] - The company reported a positive free cash flow and a decrease in interest-bearing liabilities to RMB 23.5 billion, enhancing financial resilience [13]